查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2023921

腸道健康產品市場預測—全球產品類型、產品形式、原料來源、應用、最終用戶、通路和地區分析—2034年

Gut Health Products Market Forecasts to 2034 - Global Analysis By Product Type, Product Form, Ingredient Source, Application, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球腸道健康產品市場預計到 2026 年將達到 531 億美元，並在預測期內以 8.7% 的複合年成長率成長，到 2034 年達到 1,036 億美元。

腸道健康產品涵蓋多種膳食補充劑、機能性食品和飲料，旨在透過益生菌、益生元、後生元和消化酵素來支持消化系統健康。這些產品的目標是維持腸道菌叢的平衡，而腸道菌叢平衡的重要性日益受到重視，它對包括免疫功能、心理健康和代謝調節在內的整體健康至關重要。隨著科學研究不斷揭示腸道健康與慢性疾病預防之間錯綜複雜的聯繫，該市場正在顯著擴張，吸引全球各年齡層消費者的注意。

全球胃腸道疾病發生率不斷上升

大腸激躁症、發炎性腸道疾病、胃酸逆流和便秘等疾病發生率的上升，推動了各年齡層對腸道健康解決方案的需求。久坐的生活方式、加工食品的攝取以及壓力的增加，都會導致胃腸道問題，影響全球約五分之一的成年人。醫療保健專業人員擴大推薦益生菌和益生元作為治療輕度至中度消化症狀的第一線療法。這項臨床建議，加上患者對非藥物療法的認知不斷提高，正在加速市場成長，因為消費者尋求的是維護消化系統健康的天然預防方法，而不僅僅是治療晚期症狀。

圍繞健康標籤的監管模糊之處

腸道健康產品包裝上允許的健康聲明存在許多混亂，嚴重限制了行銷活動，並削弱了消費者的信心。不同司法管轄區的監管機構對益生菌菌株的具體功效設定了不同的標準，這給跨國品牌帶來了合規挑戰。製造商必須應對複雜的核准流程，同時避免做出未經證實的療效聲明，以免受到監管處罰。這種模糊性往往導致保守的行銷策略，無法充分傳達產品的益處。結果，消費者可能會感到困惑，無法區分經過科學檢驗的產品和那些誇大其詞的產品，最終減緩了該品類在受監管市場中的成長。

透過微生物組檢測提供個人化腸道健康解決方案

新興的D2C（直接面對消費者）微生物組檢測技術為個人化產品推薦創造了前所未有的機會。如今，企業可以透過簡單的家用檢測套組分析個人的腸道菌群，從而獲得針對特定益生菌菌株和益生元纖維的個人化見解，這些益生菌和益生元纖維對每個人的獨特微生物組組成都有益。與普通保健品相比，這種精準的方法提高了產品的功效，使其能夠合理定價，並建立強大的客戶忠誠度。在消費者日益追求個人化健康解決方案而非消化器官系統健康領域通用產品的推動下，將定期檢測與客製化產品配送相結合的訂閱模式正在迅速發展。

來自機能性食品和飲料的激烈競爭

隨著大型食品飲料公司將消化器官系統健康益處融入日常消費品，傳統的腸道健康產品正面臨巨大的競爭壓力。優格、康普茶、發酵蔬菜和益生菌強化果汁等產品正日益被定位為腸道健康解決方案，為消費者提供傳統膳食補充劑以外的更多選擇。大型食品公司正利用其成熟的分銷網路和品牌知名度，試圖從專業的腸道健康品牌手中搶佔市場佔有率。這種品類融合對以膳食補充劑為主的公司構成威脅，因為消費者可能更傾向於將消化器官系統健康融入日常飲食，而不是單獨服用補充劑，這可能導致腸道健康類別的同質化。

新冠疫情的影響：

新冠疫情大大提升了消費者對免疫健康與腸道菌叢功能之間聯繫的認知。研究強調了腸道環境在免疫反應嚴重程度中的作用，這引發了人們對服用益生菌和益生元作為預防措施的廣泛興趣。疫情初期，供應鏈中斷影響了原料供應，但隨著消費者優先購買健康相關產品，需求激增。向電商和D2C（直接面對消費者）管道的轉變持續加速，許多消費者在疫情封鎖期間在線發現了腸道健康產品，並保持了這種購買習慣。這種高度關注的趨勢得以延續，為疫情後市場成長設定了高標準。

在預測期內，成人市場預計將佔據最大的市場佔有率。

在預測期內，成年人群體預計將佔據最大的市場佔有率。這主要是因為該族群消化器官系統疾病的盛行率最高，且其自由裁量權所得能力較強。成年人由於工作繁忙、食用加工食品會破壞腸道菌叢平衡，容易出現與壓力相關的消化器官系統問題，隨著老齡化，他們越來越重視預防性健康方案。此外，成年人群體對腸腦軸的連結以及消化系統健康與焦慮、憂鬱症和皮膚疾病等症狀之間的關聯也最為了解。透過社群媒體和健康領域意見領袖開展的針對成年消費者的行銷宣傳活動，能夠有效地觸達這個精通數位科技的群體，預計在整個預測期內，這些活動將在該細分市場保持主導地位。

預計在預測期內，線上零售領域將呈現最高的複合年成長率。

在預測期內，線上零售領域預計將呈現最高的成長率，徹底改變消費者發現和購買腸道健康產品的方式。電商平台提供專業的益生菌菌株、訂閱模式和客戶評估系統，幫助消費者在琳瑯滿目的產品類別中找到心儀之選。 D2C（直接面對消費者）品牌正在率先採用實體店無法複製的數位化優先策略，例如教育內容、整合式微生物組檢測和個人化建議演算法。宅配的便利性，尤其對於需要小心處理的溫度敏感型益生菌產品而言，進一步加速了線上管道的普及，因為消費者越來越期望在所有健康和保健品類中獲得無縫的數位化購物體驗。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這得益於消費者較高的健康意識、完善的醫療保健基礎設施以及對機能性食品趨勢的早期採納。該地區成熟的膳食補充劑市場擁有完善的通路，消費者對消化器官系統健康產品也充滿信心。領先的學術機構在腸道微生物組研究領域的大量投資，不僅提升了產品的功效，也促進了媒體報道，從而更好地向消費者普及相關知識。儘管法規結構較為嚴格，但它為產品功效聲明提供了明確的指南，增強了消費者的信心。眾多創新Start-Ups以及成熟的膳食補充品生產商，共同營造了競爭激烈的市場環境，不斷推出新的配方和劑型，從而在整個預測期內保持市場領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於當地居民的傳統飲食習慣（其中已包含發酵食品）以及人們對預防醫學日益增強的意識。中國、日本、韓國和印度等國家有著悠久的食用泡菜、味噌、康普茶和Lassi等發酵食品的歷史，這使得人們對腸道健康訊息的接受度不斷提高。快速的都市化和飲食西化導致消化系統疾病的盛行率上升，增加了對相關解決方案的需求。可支配收入的增加使消費者能夠購買高階產品，而不斷擴展的電子商務基礎設施也讓主要都會區以外的消費者也能享受這些產品。政府推行的強調預防性措施的醫療衛生現代化政策將進一步加速腸道健康產品的普及，使亞太地區成為腸道健康產品成長最快的市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章 全球腸道健康產品市場：依產品類型分類

  • 益生菌
    • 乳酸桿菌
    • 雙歧桿菌
    • 鏈球菌
    • 酵母來源的益生菌
    • 產孢益生菌
  • 益生元
    • 菊糖
    • 果寡糖（FOS）
    • 半乳寡糖（GOS）
    • 抗解澱粉
    • 其他益生元
  • 消化酵素
    • 蛋白酶
    • 澱粉酶
    • 脂肪酶
    • 乳糖酶
    • 其他消化酶
  • 合益素
  • 後生元

第6章 全球腸道健康產品市場：依產品形式分類

  • 膠囊和片劑
  • 粉末
  • 液體
  • 軟糖咀嚼片
  • 機能性食品的形式
  • 機能飲料

第7章 全球腸道健康產品市場：依原料來源分類

  • 植物來源
  • 動物源性
  • 微生物來源
  • 合成與生物工程

第8章 全球腸道健康產品市場：依應用分類

  • 消化系統健康
  • 免疫功能改善
  • 代謝健康
  • 體重管理
  • 心理健康（腸腦軸）
  • 女性健康
  • 兒童健康
  • 老年人營養

第9章 全球腸道健康產品市場：依最終用戶分類

  • 成人
  • 孩子們
  • 嬰兒
  • 老年人

第10章 全球腸道健康產品市場：依通路分類

  • 超級市場和大賣場
  • 藥局/藥局
  • 專賣店
  • 線上零售
  • 直接面對消費者 (DTC)

第11章 全球腸道健康產品市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Nestle SA
  • Danone SA
  • Yakult Honsha Co. Ltd.
  • PepsiCo Inc.
  • Kellogg Company
  • General Mills Inc.
  • Procter & Gamble Company
  • Abbott Laboratories
  • Amway Corporation
  • Herbalife Ltd.
  • BioGaia AB
  • Chr. Hansen Holding A/S
  • DuPont de Nemours Inc.
  • Arla Foods amba
  • Fonterra Co-operative Group Limited
Product Code: SMRC35132

According to Stratistics MRC, the Global Gut Health Products Market is accounted for $53.1 billion in 2026 and is expected to reach $103.6 billion by 2034 growing at a CAGR of 8.7% during the forecast period. Gut health products encompass a diverse range of dietary supplements, functional foods, and beverages designed to support digestive wellness through probiotics, prebiotics, postbiotics, and digestive enzymes. These products target the maintenance of a balanced gut microbiome, which is increasingly recognized as critical for overall health including immune function, mental well-being, and metabolic regulation. The market has expanded significantly as scientific research continues to unveil the complex connections between gut health and chronic disease prevention, driving consumer interest across all demographic segments worldwide.

Market Dynamics:

Driver:

Rising prevalence of digestive disorders globally

Increasing incidence of irritable bowel syndrome, inflammatory bowel disease, acid reflux, and constipation is fueling demand for gut health solutions across all age groups. Sedentary lifestyles, processed food consumption, and rising stress levels contribute to gastrointestinal complaints that affect approximately one in five adults worldwide. Healthcare professionals increasingly recommend probiotic and prebiotic interventions as first-line approaches for managing mild to moderate digestive symptoms. This clinical endorsement, combined with growing patient awareness of non-pharmaceutical options, accelerates market growth as consumers seek natural, preventative approaches to digestive wellness rather than reactive treatments for advanced conditions.

Restraint:

Regulatory ambiguity surrounding health claims

Confusion regarding permitted health claims on gut health product packaging significantly constrains marketing capabilities and consumer trust. Regulatory bodies across different jurisdictions maintain varying standards for substantiating probiotic strain-specific benefits, creating compliance challenges for multinational brands. Manufacturers must navigate complex approval pathways while avoiding unsubstantiated therapeutic claims that could trigger regulatory penalties. This ambiguity leads to conservative marketing approaches that fail to adequately communicate product benefits, potentially confusing consumers who struggle to distinguish between scientifically validated products and those making exaggerated claims, ultimately slowing category growth across regulated markets.

Opportunity:

Personalized gut health solutions through microbiome testing

Emerging direct-to-consumer microbiome testing technologies are creating unprecedented opportunities for customized product recommendations. Companies can now analyze individual gut bacterial compositions through simple at-home test kits, generating personalized insights about specific probiotic strains and prebiotic fibers that would benefit each unique microbiome profile. This precision approach increases product efficacy compared to one-size-fits-all supplements, justifying premium pricing and building strong customer loyalty. Subscription models combining periodic testing with tailored product deliveries represent a rapidly expanding segment, as consumers increasingly expect personalized health solutions rather than generic offerings in the digestive wellness category.

Threat:

Intense competition from functional food and beverage alternatives

Traditional gut health products face significant competitive pressure as mainstream food and beverage companies incorporate digestive wellness benefits into everyday consumables. Yogurt, kombucha, fermented vegetables, and probiotic-enhanced juices are increasingly positioned as gut health solutions, offering consumers alternatives to traditional supplement formats. Major food corporations leverage established distribution networks and brand recognition to capture market share from specialized gut health brands. This convergence of categories threatens supplement-focused companies as consumers may prefer incorporating digestive wellness into regular eating patterns rather than adding separate supplement regimens, potentially commoditizing the gut health category.

Covid-19 Impact:

The COVID-19 pandemic dramatically elevated consumer awareness of immune health and its connection to gut microbiome function. Research highlighting the role of gut health in immune response severity prompted widespread interest in probiotic and prebiotic supplementation as preventative measures. Supply chain disruptions initially affected raw material availability, but demand surged as consumers prioritized wellness purchases. The shift toward e-commerce and direct-to-consumer channels accelerated permanently, with many consumers discovering gut health products online during lockdowns and maintaining these purchasing habits. This heightened awareness has proven durable, establishing an elevated baseline for market growth post-pandemic.

The Adults segment is expected to be the largest during the forecast period

The Adults segment is expected to account for the largest market share during the forecast period, driven by the highest prevalence of digestive concerns within this demographic and greater discretionary spending power. Adults experience stress-related digestive issues from demanding work schedules, consume processed foods that disrupt microbiome balance, and increasingly seek preventative health solutions as they age. This group also demonstrates the highest awareness of gut-brain axis connections and the relationship between digestive health and conditions including anxiety, depression, and skin disorders. Marketing campaigns targeting adult consumers through social media and wellness influencers effectively reach this digitally engaged demographic, maintaining the segment's dominant market position throughout the forecast timeline.

The Online Retail segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Online Retail segment is predicted to witness the highest growth rate, transforming how consumers discover and purchase gut health products. E-commerce platforms offer access to specialized probiotic strains, subscription delivery models, and customer review systems that help consumers navigate the crowded category. Direct-to-consumer brands have pioneered digital-first strategies including educational content, microbiome testing integration, and personalized recommendation algorithms that cannot be replicated in physical retail environments. The convenience of home delivery, particularly for temperature-sensitive probiotic products requiring careful handling, further accelerates online channel adoption as consumers increasingly expect seamless digital purchasing experiences across all health and wellness categories.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high consumer awareness, strong healthcare infrastructure, and early adoption of functional food trends. The region's mature dietary supplements market provides established distribution channels and consumer trust in digestive health products. Significant investment in gut microbiome research from leading academic institutions validates product benefits and drives media coverage that educates consumers. Regulatory frameworks, while stringent, provide clear pathways for product claims that build consumer confidence. The presence of numerous innovative startups alongside established supplement manufacturers creates a competitive environment that continuously introduces new formulations and delivery formats, maintaining market leadership throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by traditional dietary practices that already incorporate fermented foods and growing awareness of preventative healthcare. Countries including China, Japan, South Korea, and India have long histories of consuming fermented products like kimchi, miso, kombucha, and lassi, creating cultural receptivity to gut health messaging. Rapid urbanization and Westernization of diets are increasing digestive disorder prevalence, driving demand for targeted solutions. Rising disposable incomes enable premium product purchases, while expanding e-commerce infrastructure reaches consumers beyond major metropolitan areas. Government healthcare modernization initiatives emphasizing preventative approaches further accelerate adoption, positioning Asia Pacific as the fastest-growing regional market for gut health products.

Key players in the market

Some of the key players in Gut Health Products Market include Nestle S.A., Danone S.A., Yakult Honsha Co. Ltd., PepsiCo Inc., Kellogg Company, General Mills Inc., Procter & Gamble Company, Abbott Laboratories, Amway Corporation, Herbalife Ltd., BioGaia AB, Chr. Hansen Holding A/S, DuPont de Nemours Inc., Arla Foods amba, and Fonterra Co-operative Group Limited.

Key Developments:

In March 2026, Fonterra completed the sale of its Mainland Group to Lactalis for $3.845 billion, a strategic move to exit consumer-facing retail and pivot toward high-value B2B gut health ingredients.

In February 2026, eneral Mills debuted its 2026 product lineup, which includes an expanded range of Nature Valley protein granolas and fiber-dense cereals designed to support digestive regularity.

In January 2025, Amway launched the Nutrilite(TM) Begin 30 Holistic Wellness Program, a 30-day guided journey centered on gut health featuring the Begin Daily GI Primer and Balance within Probiotic.

Product Types Covered:

  • Probiotics
  • Prebiotics
  • Digestive Enzymes
  • Synbiotics
  • Postbiotics

Product Forms Covered:

  • Capsules & Tablets
  • Powders
  • Liquids
  • Gummies & Chewables
  • Functional Food Formats
  • Functional Beverages

Ingredient Sources Covered:

  • Plant-Based
  • Animal-Based
  • Microbial-Based
  • Synthetic & Bioengineered

Applications Covered:

  • Digestive Health
  • Immunity Enhancement
  • Metabolic Health
  • Weight Management
  • Mental Health (Gut-Brain Axis)
  • Women's Health
  • Pediatric Health
  • Elderly Nutrition

End Users Covered:

  • Adults
  • Children
  • Infants
  • Geriatric Population

Distribution Channels Covered:

  • Supermarkets & Hypermarkets
  • Pharmacies & Drug Stores
  • Specialty Stores
  • Online Retail
  • Direct-to-Consumer (DTC)

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Gut Health Products Market, By Product Type

  • 5.1 Probiotics
    • 5.1.1 Lactobacillus
    • 5.1.2 Bifidobacterium
    • 5.1.3 Streptococcus
    • 5.1.4 Yeast-Based Probiotics
    • 5.1.5 Spore-Forming Probiotics
  • 5.2 Prebiotics
    • 5.2.1 Inulin
    • 5.2.2 Fructooligosaccharides (FOS)
    • 5.2.3 Galactooligosaccharides (GOS)
    • 5.2.4 Resistant Starch
    • 5.2.5 Other Prebiotics
  • 5.3 Digestive Enzymes
    • 5.3.1 Protease
    • 5.3.2 Amylase
    • 5.3.3 Lipase
    • 5.3.4 Lactase
    • 5.3.5 Other Digestive Enzymes
  • 5.4 Synbiotics
  • 5.5 Postbiotics

6 Global Gut Health Products Market, By Product Form

  • 6.1 Capsules & Tablets
  • 6.2 Powders
  • 6.3 Liquids
  • 6.4 Gummies & Chewables
  • 6.5 Functional Food Formats
  • 6.6 Functional Beverages

7 Global Gut Health Products Market, By Ingredient Source

  • 7.1 Plant-Based
  • 7.2 Animal-Based
  • 7.3 Microbial-Based
  • 7.4 Synthetic & Bioengineered

8 Global Gut Health Products Market, By Application

  • 8.1 Digestive Health
  • 8.2 Immunity Enhancement
  • 8.3 Metabolic Health
  • 8.4 Weight Management
  • 8.5 Mental Health (Gut-Brain Axis)
  • 8.6 Women's Health
  • 8.7 Pediatric Health
  • 8.8 Elderly Nutrition

9 Global Gut Health Products Market, By End User

  • 9.1 Adults
  • 9.2 Children
  • 9.3 Infants
  • 9.4 Geriatric Population

10 Global Gut Health Products Market, By Distribution Channel

  • 10.1 Supermarkets & Hypermarkets
  • 10.2 Pharmacies & Drug Stores
  • 10.3 Specialty Stores
  • 10.4 Online Retail
  • 10.5 Direct-to-Consumer (DTC)

11 Global Gut Health Products Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Nestle S.A.
  • 14.2 Danone S.A.
  • 14.3 Yakult Honsha Co. Ltd.
  • 14.4 PepsiCo Inc.
  • 14.5 Kellogg Company
  • 14.6 General Mills Inc.
  • 14.7 Procter & Gamble Company
  • 14.8 Abbott Laboratories
  • 14.9 Amway Corporation
  • 14.10 Herbalife Ltd.
  • 14.11 BioGaia AB
  • 14.12 Chr. Hansen Holding A/S
  • 14.13 DuPont de Nemours Inc.
  • 14.14 Arla Foods amba
  • 14.15 Fonterra Co-operative Group Limited

List of Tables

  • Table 1 Global Gut Health Products Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Gut Health Products Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Gut Health Products Market Outlook, By Probiotics (2023-2034) ($MN)
  • Table 4 Global Gut Health Products Market Outlook, By Lactobacillus (2023-2034) ($MN)
  • Table 5 Global Gut Health Products Market Outlook, By Bifidobacterium (2023-2034) ($MN)
  • Table 6 Global Gut Health Products Market Outlook, By Streptococcus (2023-2034) ($MN)
  • Table 7 Global Gut Health Products Market Outlook, By Yeast-Based Probiotics (2023-2034) ($MN)
  • Table 8 Global Gut Health Products Market Outlook, By Spore-Forming Probiotics (2023-2034) ($MN)
  • Table 9 Global Gut Health Products Market Outlook, By Prebiotics (2023-2034) ($MN)
  • Table 10 Global Gut Health Products Market Outlook, By Inulin (2023-2034) ($MN)
  • Table 11 Global Gut Health Products Market Outlook, By Fructooligosaccharides (FOS) (2023-2034) ($MN)
  • Table 12 Global Gut Health Products Market Outlook, By Galactooligosaccharides (GOS) (2023-2034) ($MN)
  • Table 13 Global Gut Health Products Market Outlook, By Resistant Starch (2023-2034) ($MN)
  • Table 14 Global Gut Health Products Market Outlook, By Other Prebiotics (2023-2034) ($MN)
  • Table 15 Global Gut Health Products Market Outlook, By Digestive Enzymes (2023-2034) ($MN)
  • Table 16 Global Gut Health Products Market Outlook, By Protease (2023-2034) ($MN)
  • Table 17 Global Gut Health Products Market Outlook, By Amylase (2023-2034) ($MN)
  • Table 18 Global Gut Health Products Market Outlook, By Lipase (2023-2034) ($MN)
  • Table 19 Global Gut Health Products Market Outlook, By Lactase (2023-2034) ($MN)
  • Table 20 Global Gut Health Products Market Outlook, By Other Digestive Enzymes (2023-2034) ($MN)
  • Table 21 Global Gut Health Products Market Outlook, By Synbiotics (2023-2034) ($MN)
  • Table 22 Global Gut Health Products Market Outlook, By Postbiotics (2023-2034) ($MN)
  • Table 23 Global Gut Health Products Market Outlook, By Product Form (2023-2034) ($MN)
  • Table 24 Global Gut Health Products Market Outlook, By Capsules & Tablets (2023-2034) ($MN)
  • Table 25 Global Gut Health Products Market Outlook, By Powders (2023-2034) ($MN)
  • Table 26 Global Gut Health Products Market Outlook, By Liquids (2023-2034) ($MN)
  • Table 27 Global Gut Health Products Market Outlook, By Gummies & Chewables (2023-2034) ($MN)
  • Table 28 Global Gut Health Products Market Outlook, By Functional Food Formats (2023-2034) ($MN)
  • Table 29 Global Gut Health Products Market Outlook, By Functional Beverages (2023-2034) ($MN)
  • Table 30 Global Gut Health Products Market Outlook, By Ingredient Source (2023-2034) ($MN)
  • Table 31 Global Gut Health Products Market Outlook, By Plant-Based (2023-2034) ($MN)
  • Table 32 Global Gut Health Products Market Outlook, By Animal-Based (2023-2034) ($MN)
  • Table 33 Global Gut Health Products Market Outlook, By Microbial-Based (2023-2034) ($MN)
  • Table 34 Global Gut Health Products Market Outlook, By Synthetic & Bioengineered (2023-2034) ($MN)
  • Table 35 Global Gut Health Products Market Outlook, By Application (2023-2034) ($MN)
  • Table 36 Global Gut Health Products Market Outlook, By Digestive Health (2023-2034) ($MN)
  • Table 37 Global Gut Health Products Market Outlook, By Immunity Enhancement (2023-2034) ($MN)
  • Table 38 Global Gut Health Products Market Outlook, By Metabolic Health (2023-2034) ($MN)
  • Table 39 Global Gut Health Products Market Outlook, By Weight Management (2023-2034) ($MN)
  • Table 40 Global Gut Health Products Market Outlook, By Mental Health (Gut-Brain Axis) (2023-2034) ($MN)
  • Table 41 Global Gut Health Products Market Outlook, By Women's Health (2023-2034) ($MN)
  • Table 42 Global Gut Health Products Market Outlook, By Pediatric Health (2023-2034) ($MN)
  • Table 43 Global Gut Health Products Market Outlook, By Elderly Nutrition (2023-2034) ($MN)
  • Table 44 Global Gut Health Products Market Outlook, By End User (2023-2034) ($MN)
  • Table 45 Global Gut Health Products Market Outlook, By Adults (2023-2034) ($MN)
  • Table 46 Global Gut Health Products Market Outlook, By Children (2023-2034) ($MN)
  • Table 47 Global Gut Health Products Market Outlook, By Infants (2023-2034) ($MN)
  • Table 48 Global Gut Health Products Market Outlook, By Geriatric Population (2023-2034) ($MN)
  • Table 49 Global Gut Health Products Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 50 Global Gut Health Products Market Outlook, By Supermarkets & Hypermarkets (2023-2034) ($MN)
  • Table 51 Global Gut Health Products Market Outlook, By Pharmacies & Drug Stores (2023-2034) ($MN)
  • Table 52 Global Gut Health Products Market Outlook, By Specialty Stores (2023-2034) ($MN)
  • Table 53 Global Gut Health Products Market Outlook, By Online Retail (2023-2034) ($MN)
  • Table 54 Global Gut Health Products Market Outlook, By Direct-to-Consumer (DTC) (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.